GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Mainz Biomed NV (NAS:MYNZ) » Definitions » Ending Cash Position

MYNZ (Mainz Biomed NV) Ending Cash Position : $0.00 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Mainz Biomed NV Ending Cash Position?

Mainz Biomed NV's Ending Cash Position for the quarter that ended in Dec. 2024 was $0.00 Mil.

Mainz Biomed NV's quarterly Ending Cash Position declined from Dec. 2023 ($7.07 Mil) to Jun. 2024 ($0.00 Mil) but then stayed the same from Jun. 2024 ($0.00 Mil) to Dec. 2024 ($0.00 Mil).

Mainz Biomed NV's annual Ending Cash Position declined from Dec. 2022 ($17.14 Mil) to Dec. 2023 ($7.07 Mil) and declined from Dec. 2023 ($7.07 Mil) to Dec. 2024 ($6.24 Mil).

Mainz Biomed NV Ending Cash Position Historical Data

The historical data trend for Mainz Biomed NV's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mainz Biomed NV Ending Cash Position Chart

Mainz Biomed NV Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Ending Cash Position
Get a 7-Day Free Trial 0.12 8.73 17.14 7.07 6.24

Mainz Biomed NV Quarterly Data
Dec19 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Jun24 Dec24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.91 9.32 7.07 - -

Mainz Biomed NV Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Mainz Biomed NV's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=7.071+-0.835
=6.24

Mainz Biomed NV's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0+0
=0.00

Mainz Biomed NV Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Mainz Biomed NV's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Mainz Biomed NV Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Mainz Biomed NV (NAS:MYNZ) » Definitions » Ending Cash Position
Comparable Companies
PRPO BIAF STRR CHEK XWEL FUNI TTOO ISPC IDXG NDRA TMO DHR XSWX:LONN IDXX A IQV SHSE:603259 MTD NTRA WAT
Traded in Other Exchanges
N/A
Address
Robert Koch Strasse 50, Sirius Gutenberg Park, Mainz, RP, DEU, 55129
Website
https://www.mainzbiomed.com
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.